No Data
No Data
Trending Stocks Today | Exicure Shoots up 73.75% Post-Market
BofA Securities Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $25
Buy Rating Affirmed for Zai Lab on Robust Drug Sales Growth and Strong Market Position
Hong Kong stocks have fluctuated | Zai Lab (09688) rose more than 6%, with 7.4494 million shares increased by small stakes, and Ajumode's growth momentum is strong.
Zai Lab (09688) rose more than 6%, as of press time, up 6.22%, at HKD 16.74, with a turnover of HKD 18.43 million.
Zai Lab Limited's (NASDAQ:ZLAB) Path To Profitability
Zai Lab (09688.HK) received a shareholding of 7.4494 million shares from JPMorgan.
According to the latest equity disclosure information from the Hong Kong Stock Exchange, on September 4, 2024, zai lab (09688.HK) increased its shareholding by JPMorgan Chase & Co. to an average price of HK$14.9233 per share, with a total investment of approximately HK$0.111 billion. After the increase, JPMorgan Chase & Co. currently holds a total of 135,826,437 shares, with a shareholding ratio of 13.63%, up from 12.88%.
No Data
No Data